Jones Day's Anthony Insogna, Randy Kay, and Edward Reines named Top Intellectual Property Lawyers by the Daily Journal

Jones Day partners Anthony Insogna, Randy Kay, and Edward Reines have been named to the Daily Journal's list of Top Intellectual Property Lawyers in California for 2025. Honorees are selected based on their overall impact/contribution within the intellectual property field, prioritizing lawyers who have influenced the development of case law and helped shape the legal profession.

Named to Daily Journal's Top IP Lawyer list for the tenth time, Mr. Insogna leads Jones Day's global Intellectual Property Practice, with 220 professionals serving clients for their litigations, IP portfolios, technology-related transactions, and all other IP needs and issues. In his own practice, Mr. Insogna, a life sciences lawyer, has more than 30 years of experience leading patent litigation around the globe, developing patent strategies for drug candidates and FDA-approved products, and advising on technology-driven transactions for corporations and private equity firms. He litigates Hatch-Waxman, competitor versus competitor, and PTAB matters, including enforcing and defending breakthrough technologies in immuno-oncology, gene editing, and gene therapy, among other fields.

Mr. Kay, who appears on Daily Journal's Top IP Lawyer list for the eleventh time, is a partner in Jones Day's Intellectual Property Practice and serves as chair of the Firm's global Trade Secrets area of focus. Mr. Kay is an internationally recognized leader in U.S. trade secret litigation, who has litigated cases at the intersection of patent and trade secret law for over twenty-five years. These matters include disputes over ownership of pending patent applications and issued patents that are claimed to be derived from stolen trade secrets. Mr. Kay's recent IP matters involve technologies for lab-on-a-chip, avionics, cancer therapies, pharmaceuticals, casino gaming, chemicals, software, telecommunications, semiconductors, and healthcare innovations. His recent highlights include achieving a complete victory in arbitration and litigation proceedings on behalf of a European scientific company in its trade secret and contract dispute against a former collaboration partner.

A notable recent addition to Jones Day's impressive roster of IP lawyers, Mr. Reines is a leading first-chair trial lawyer with extensive appellate experience. He is particularly adept at handling complex competitor-versus-competitor disputes in the life sciences, biotech, and high-technology industries. Mr. Reines has a strong track record representing clients in high-stakes, multidistrict patent litigation. Recent achievements before joining Jones Day in 2025 include overturning a $96 million verdict in a patent case involving genetic technologies and winning a $45 million verdict in a Lanham Act false advertising lawsuit regarding diagnostic tests.